Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health

Research output: Contribution to journalJournal articleResearch

  • EFSA Scientific Committee
  • Simon More
  • Vasileios Bampidis
  • Diane Benford
  • Claude Bragard
  • Thorhallur Halldorsson
  • Antonio Hernández-Jerez
  • Susanne Hougaard Bennekou
  • Kostas Koutsoumanis
  • Claude Lambré
  • Kyriaki Machera
  • Hanspeter Naegeli
  • Josef Schlatter
  • Dieter Schrenk
  • Vittorio Silano (deceased)
  • Dominique Turck
  • Maged Younes
  • Jacqueline Castenmiller
  • Qasim Chaudhry
  • Francesco Cubadda
  • Roland Franz
  • David Gott
  • Jan Mast
  • Alicja Mortensen
  • Agnes G. Oomen
  • Stefan Weigel
  • Eric Barthelemy
  • Ana Rincon
  • José Tarazona
  • Reinhilde Schoonjans
Abstract The EFSA has updated the Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain, human and animal health. It covers the application areas within EFSA’s remit, including novel foods, food contact materials, food/feed additives and pesticides. The updated guidance, now Scientific Committee Guidance on nano risk assessment (SC Guidance on Nano-RA), has taken account of relevant scientific studies that provide insights to physico-chemical properties, exposure assessment and hazard characterisation of nanomaterials and areas of applicability. Together with the accompanying Guidance on Technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles (Guidance on Particle-TR), the SC Guidance on Nano-RA specifically elaborates on physico-chemical characterisation, key parameters that should be measured, methods and techniques that can be used for characterisation of nanomaterials and their determination in complex matrices. The SC Guidance on Nano-RA also details aspects relating to exposure assessment and hazard identification and characterisation. In particular, nanospecific considerations relating to in vitro/in vivo toxicological studies are discussed and a tiered framework for toxicological testing is outlined. Furthermore, in vitro degradation, toxicokinetics, genotoxicity, local and systemic toxicity as well as general issues relating to testing of nanomaterials are described. Depending on the initial tier results, additional studies may be needed to investigate reproductive and developmental toxicity, chronic toxicity and carcinogenicity, immunotoxicity and allergenicity, neurotoxicity, effects on gut microbiome and endocrine activity. The possible use of read-across to fill data gaps as well as the potential use of integrated testing strategies and the knowledge of modes or mechanisms of action are also discussed. The Guidance proposes approaches to risk characterisation and uncertainty analysis.
Original languageEnglish
Article numbere06768
JournalEFSA Journal
Volume19
Issue number8
Pages (from-to)1-111
Number of pages111
ISSN1831-4732
DOIs
Publication statusPublished - 2021

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 275765441